Trends in Molecular Medicine
ReviewCarbapenem resistance in Enterobacteriaceae: here is the storm!
Section snippets
Carbapenem resistance: a worsening situation
Enterobacteriaceae are rod-shaped, Gram-negative bacteria that are normal inhabitants of the intestinal flora and among the most common human pathogens, causing infections that range from cystitis to pyelonephritis, septicemia, pneumonia, peritonitis, meningitis, and device-associated infections. They are the most common source of both community- and hospital-acquired infections, with Escherichia coli being by far the most important pathogen for humans. Enterobacteriaceae spread easily between
Non-carbapenemase mediated carbapenem resistance in Enterobacteriaceae
The outer membrane of Gram-negative bacteria forms a hydrophobic barrier that protects the cell against external agents such as heavy metals and detergents. This membrane contains specific proteins, called porins, that form hydrophilic channels to allow the selective uptake of essential nutrients and other compounds, including antibiotics (Figure 1) 5, 6. The primary porins in Enterobacteriaceae involved in taking up antibiotics belong to the OmpF or OmpC families [6]. Thus, any changes in the
Carbapenemase-mediated carbapenem resistance in Enterobacteriaceae
The first carbapenemases identified in Enterobacteriaceae were SME-1 in London in 1982 [22] and IMI-1 in the USA in 1984 [23]. The first carbapenemase reported as a serine carbapenemase in the primary literature was the chromosomally-encoded NmcA from an Enterobacter cloacae clinical isolate [24]. Since then, carbapenem-resistant Enterobacteriaceae have been reported worldwide, primarily as a consequence of widespread acquisition of carbapenemase genes [25]. A large variety of carbapenemases
The Ambler class A carbapenemases
Three major types of class A carbapenemases are known, corresponding to the NmcA/IMI, SME, and KPC enzymes [26]. All three enzyme types hydrolyze a broad variety of β-lactams including penicillins, cephalosporins, carbapenems, and aztreonam (Table 1) by a hydrolytic mechanism involving an active site serine at position 70 (Ambler numbering of class A β-lactamases) [27]. Their hydrolytic activity is inhibited in vitro by clavulanic acid and tazobactam (Table 1). A fourth type of enzyme
The class B metallo β-lactamases (MBL)
Class B β-lactamases exhibit a broad spectrum of hydrolytic activity including all penicillins, cephalosporins, and carbapenems, with the exception of monobactam aztreonam (Table 1). Their activity is not inhibited by commercially available β-lactamase inhibitors (clavulanic acid, tazobactam, or sulbactam). Hydrolysis is dependent on the interaction of the β-lactam with Zn2+ ion(s) in the active site, explaining the inhibition of their activity by EDTA, a chelator of divalent cations (Table 1).
The class D carbapenemases of the OXA-48 type
Class D β-lactamases, also named OXAs for ‘oxacillinases’, include 232 enzymes, with a few variants possessing some carbapenemase activity. With the exception of one variant (OXA-163) that has a very weak carbapenemase activity, carbapenem-hydrolyzing class D β-lactamases (CHDLs) do not hydrolyze expanded-spectrum cephalosporins (Table 1). Overall, the carbapenemase activity of CHDLs is weak and is not inhibited by either clavulanic acid or by EDTA, but is inhibited by NaCl (Table 1).
Although
Concluding remarks
As highlighted in this review, resistance to carbapenems in Enterobacteriaceae may result either from expression of carbapenemases or by combined effects of β-lactamases with no (or very weak) intrinsic carbapenemase activity (i.e. ESBLs or cephalosporinases) and decreased outer membrane permeability.
The real prevalence of carbapenemase-producing bacterial strains remains unknown because many countries worldwide do not report rates of antibiotic susceptibility. Therefore, the worldwide spread
Acknowledgments
This work was funded by grants from the UMRS 914 (INSERM and Université Paris XI).
References (88)
- et al.
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Lancet Infect. Dis.
(2008) Extended-spectrum β-lactamases and the permeability barrier
Clin. Microbiol. Infect.
(2008)Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss
Int. J. Antimicrob. Agents
(2007)Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes
Biochem. Biophys. Res. Commun.
(2003)Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit
Diagn. Microbiol. Infect. Dis.
(2011)Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria
FEMS Microbiol. Lett.
(2004)The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Lancet Infect. Dis.
(2009)- et al.
Biochemical characterization of the carbapenem-hydrolyzing β-lactamase AsbM1 from Aeromonas sobria AER 14 M: a member of a novel subgroup of metallo-β-lactamases
FEMS Microbiol. Lett.
(1996) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Lancet Infect. Dis.
(2010)Balkan NDM-1: escape or transplant?
Lancet Infect. Dis.
(2011)